Charles River Laboratories Announces Governance Updates and Strategic Review to Enhance Long-Term Stockholder Value

About this update from Charles River Laboratories International, Inc.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1245,"height":326,"url":"https://media.zenfs.com/en/business-wire.com/67d6f14246008f9f6009147279a88080"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/5cv4nrq4gQO5fL8lj.sRUw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTI1MTtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/67d6f14246008f9f6009147279a88080","width":960,"height":251},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/mwkBXGH4ixVoSrwWNA3Lcw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD02Mjg7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/67d6f14246008f9f6009147279a88080","width":1200,"height":314}},"lazy":false},{"type":"text","content":"– Board Approves Appointment of Four New Directors –","length":52,"tagName":"p","attribs":{}},{"type":"text","content":"– Strategic Planning and Capital Allocation Committee of the Board to Conduct Comprehensive Strategic Review of the Company’s Business –","length":136,"tagName":"p","attribs":{}},{"type":"text","content":"– Enters into Cooperation Agreement with Elliott Investment Management –","length":72,"tagName":"p","attribs":{}},{"type":"text","content":"WILMINGTON, Mass., May 07, 2025--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced that four new directors will join its Board of Directors and that four long-time members of the Board will not seek re-election at the 2025 Annual Meeting of Shareholders. The Company also announced changes to its Board committees and a strategic review of the Company’s business focused on enhancing long-term value for shareholders.","length":459,"tagName":"p"},{"type":"text","content":"Charles River’s Board of Directors has agreed to appoint four new directors, Steven Barg, Abe Ceesay, Mark Enyedy, and Paul Graves, who will join the Board effective following the 2025 Annual Meeting of Shareholders to be held on May 20, 2025. Four existing directors, Robert Bertolini, Deborah Kochevar, George Massaro and Richard Wallman, have announced their intentions to not seek re-election at the end of their previously elected terms at the 2025 Annual Meeting. Following the new director appointments, the Company's Board will consist of eleven directors, nine of whom will be independent.","length":602,"tagName":"p"},{"type":"text"...

More updates from Charles River Laboratories International, Inc.